“Being in clinical trials required a lot of travel, which was costly and tough on my body.”– Katie Doble, cancer trial participant in Colorado For Katie, joining a clinical trial meant leaving her home state and…
Depression affects over a billion people worldwide and remains a leading cause of disability and lost productivity. In the U.S., nearly one in five adults experiences a mental health condition each year, yet fewer than half…
October is a time to recognize both how far we’ve come in improving breast cancer care and highlight the recent advances in its management towards improving the quality of life of breast cancer survivors and caregivers….
Throwback to October 13th! We were honored to power the Clinical Trial Finder for the groundbreaking Reflections initiative, a program transforming how communities engage with clinical research. Designed to enhance diversity in clinical trials and raise…
Can a pretzel-shaped device rewrite the story of bladder cancer? In September 2025, the U.S. Food and Drug Administration (FDA) approved Inlexzo™ (formerly TAR-200), a novel intravesical gemcitabine delivery system developed by Johnson & Johnson for…
When Ryan Frazier was only three months old, his family received life-changing news: he had acute myeloid leukemia (AML). Despite multiple rounds of chemotherapy, the cancer came back and spread to his central nervous system. His…
🏈 Kicking Off Progress in ALS Research – We’re honored to share that TrialX’s global clinical trial finder now powers the ALS Network’s Trial Finder—an AI-driven platform designed to help individuals easily discover clinical trials focused on amyotrophic…
